Uniindia: Hyderabad Nov 2 (UNI) AIG (Asian Institute of Gastroenterology) Hospitals along with the Asian Healthcare Foundation, Centre for Cellular & Molecular Biology(CCMB) Hyderabad and Institute of Life Sciences, in their study successfully proved that the Monoclonal antibody Therapy reduces severe disease and death in high-risk individuals infected with the Delta Variant of SARS CoV 2 by 100 per cent.
One crore people suffer from long Covid in India: Study asianage.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asianage.com Daily Mail and Mail on Sunday newspapers.
One crore people suffer from long Covid in India: Study deccanchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from deccanchronicle.com Daily Mail and Mail on Sunday newspapers.